The role of rituximab in a case of EBV-related lymphoproliferative disease presenting with haemophagocytosis

Netherlands Journal of Medicine

Volumn 67, Issue 8, 2009, Pages 364-365

  Bosman, G ^a   Langemeijer, S M C ^a   Hebeda, K M ^a   Raemaekers, J M M ^a   Pickkers, P ^a   Van Der Velden, W J F M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEXAMETHASONE; DOXORUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; ANAMNESIS; ANOREXIA; BACTERIAL PERITONITIS; CASE REPORT; CERVICAL LYMPHADENOPATHY; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS; ERYTHROPHAGOCYTOSIS; FEMALE; FEVER; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HEPATOSPLENOMEGALY; HUMAN; JAUNDICE; LARGE CELL CARCINOMA; LETTER; LYMPHOPROLIFERATIVE DISEASE; MULTIPLE CYCLE TREATMENT; MYALGIA; PANCYTOPENIA; RASH; ULCERATIVE COLITIS; VIRUS INFECTION; VIRUS LOAD;

ADULT; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOLOGIC FACTORS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; PREDNISONE; VINCRISTINE;

EID: 70349687043     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Wijsman CA, Roeters van Lennep JE, von den Borne PA, Fogteloo AJ. A diagnostic difficulty: two cases of haemophagocytic syndrome in adults. Neth J Med. 2009;67:29-31.
2. Henter JI, Horne A, Arico M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124-131 (Pubitemid 44958267)
3. Sato S, Kawashima H, Oshiro H, et al. Virological and immunological characteristics of a 19-year-old Japanese female with fatal outcome with Epstein-Barr virus-associated hemophagocytic syndrome. J Clin Virol. 2004;31:235-238 (Pubitemid 39311804)
4. Kasahara Y, Yachie A. Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Crit Rev Oncol Hematol. 2002;44:283-294 (Pubitemid 35435293)
5. Imashuku S, Tabata Y, Teramura T, Hibi S. Treatment strategies for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH). Leuk Lymphoma. 2000;39:37-49. (Pubitemid 30657806)
6. Frey NV, Tsai DE. The management of posttransplant lymphoproliferative disorder. Med Oncol. 2007;24:125-136